Navigation Links
Nephrologists summarize new renal research during public policy news briefing at Renal Week

Renal experts will summarize important new research on the topics of cardiovascular risk in chronic kidney disease, consequences of acute kidney injury, racial and ethnic disparities of kidney disease, and anemia management in kidney disease patients, being presented during the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco at a policy-centered news briefing on Saturday, November 3.

We hope that by highlighting significant research that could directly impact public health in America, we can ultimately improve health outcomes, said Jonathan Himmelfarb, MD of Maine Medical Center, Chair of ASNs Public Policy Board and moderator of the briefing.

Following a brief introduction by Dr. Himmelfarb, Mark J. Sarnak, MD, FASN of Tufts-New England Medical Center will discuss the link between chronic kidney disease (CKD) and cardiovascular disease (CVD) in his briefing presentation, The CKD - CVD Connection. Chi-yuan Hsu, MD, MS of University of California, San Francisco will address The Consequences of Acute Kidney Injury. The third topic, Race, Ethnicity in Outcomes of Patients with Kidney Disease (Health Disparities) will be presented by Neil R. Powe, MD, MPH, MBA, FASN of the Johns Hopkins University School of Medicine. Lynda A. Szczech, MD, MSCE, FASN of Duke University Medical Center will conclude the briefing with a discussion on The Treatment of Anemia in Kidney Disease.

The Public Policy News Briefing will take place on Saturday, November 3, 2007 from 12:15 pm to 1:15 pm in Room 236 of the Moscone Center South in San Francisco.


Contact: Shari Leventhal
American Society of Nephrology

Page: 1

Related medicine news :

1. Nephrologists Reassess Disaster Response Strategies
2. Renal problem alleviated
3. Increase in renal problems
4. Effect of drug on Renal Cancer
5. Renal problem increased
6. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
7. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
8. A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma
9. Negative Impact Of Hepatitis C Infection In Renal Transplant Recipients
10. Clinical Renal Trails Do Not Have Sufficient Women Participants
11. Adrenal Suppression not predicted by inhaled corticosteroids
Post Your Comments:
(Date:10/13/2015)... ... , ... Sir Grout of Greater Boston donated an expansive, seven room ... House Charities® (RMHC®). This donation was made in an effort to give back to ... inception. , “We believe strongly in the Ronald McDonald House Charities, and they are ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... its newest technology platform, ENGAGE, at HIMSS’s Patient Engagement Summit . HealthAware ... , ENGAGE delivers innovative health programs and interventions via mobile devices that provide ...
(Date:10/13/2015)... ... October 13, 2015 , ... Element ... products, introduced a new company, RightSensor™ LLC, an Internet of Things (IoT) hardware ... RightSensor™ provides a fully-managed approach for customers requiring sensor hardware for critical data ...
(Date:10/13/2015)... ... , ... NavaFit Inc. today announced the launch of its NavaFit app for ... local fitness & sporting events, and stay motivated. Users can download the ... us to get more serious about fitness and wellness, individuals are constantly looking for ...
(Date:10/13/2015)... , ... October 13, 2015 ... ... Omega-3, a first-of-its kind product that targets the unique health needs of ... of the American Pregnancy Association ( ), utilizes Nordic Naturals’ exclusive, ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... , Oct. 13, 2015  A minimally-invasive treatment just ... the United States.  After more than 10 years of ... 9 approved the use of High Intensity Focused Ultrasound ... cells while protecting surrounding tissue and minimizing chances for ... George Suarez , a pioneering Miami ...
(Date:10/13/2015)... N.J. , Oct. 13, 2015  ContraVir ... the "Company"), a biopharmaceutical company focused on the ... announced the closing of its previously announced underwritten ... stock and warrants to purchase up to 3,000,000 ... fixed combined price to the public of $3.00. ...
(Date:10/13/2015)... , Oct. 13, 2015  Measurement in accountable ... and balancing financial incentives, but gaps in measurement ... care and health systems. A new, peer-reviewed ... Managed Care explores measurement gaps for ... sets. --> --> ...
Breaking Medicine Technology: